RGS16
Regulator of G-protein signaling 16
Also known as: A28-RGS14, RGS-r, RGS16_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15492
- Gene
- RGS16
- Ensembl
- ENSG00000143333
- Chromosome
- 1
- Canonical length
- 202 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
The protein encoded by this gene belongs to the 'regulator of G protein signaling' family. It inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits. It also may play a role in regulating the kinetics of signaling in the phototransduction cascade. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
202 residues, UniProt reviewed canonical sequence.
>O15492|RGS16
1 MCRTLAAFPT TCLERAKEFK TRLGIFLHKS ELGCDTGSTG KFEWGSKHSK ENRNFSEDVL
61 GWRESFDLLL SSKNGVAAFH AFLKTEFSEE NLEFWLACEE FKKIRSATKL ASRAHQIFEE
121 FICSEAPKEV NIDHETHELT RMNLQTATAT CFDAAQGKTR TLMEKDSYPR FLKSPAYRDL
181 AAQASAASAT LSSCSLDEPS HTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RGS16 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 97 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 97 nTPM
- retina: 56 nTPM
- pituitary gland: 48 nTPM
- adipose tissue: 38 nTPM
- urinary bladder: 36 nTPM
- lung: 27 nTPM
Single-cell type
- pericytes: 498 nCPM
- vascular smooth muscle cells: 398 nCPM
- retinal bipolar cells: 358 nCPM
- extravillous trophoblasts: 276 nCPM
- decidual stromal cells: 270 nCPM
- müller glia: 252 nCPM
Immune cell
- plasmacytoid DC: 9.7 nTPM
- memory B-cell: 4.7 nTPM
- memory CD4 T-cell: 4.3 nTPM
- T-reg: 2.9 nTPM
- basophil: 2.6 nTPM
- NK-cell: 2.6 nTPM
Brain region
- thalamus: 276 nTPM
- midbrain: 145 nTPM
- hypothalamus: 95 nTPM
- amygdala: 39 nTPM
- white matter: 30 nTPM
- medulla oblongata: 30 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.6
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.43
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- G protein-coupled receptor signaling pathway
- negative regulation of signal transduction
- positive regulation of GTPase activity
- regulation of G protein-coupled receptor signaling pathway
- visual perception
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RGS16 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RGS16 as an antibody target. Whether an autoantibody or antibody against RGS16 could matter depends on whether native RGS16 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RGS16 is annotated at the cell surface, where native RGS16 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label RGS16 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...